BHVN
HealthcareBiohaven Ltd.
$9.58-0.33 (-3.33%)
Prev Close
$9.91
Open
$10.00
High
$10.37
Low
$9.51
Volume
1.23M
Market Cap
$1.08B
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Biohaven Ltd. (BHVN) has been dominated by buying, with 4 insider purchases totaling $33.14M and 5 insider sales totaling $153.7K. The most recent insider transaction was by Buten Matthew (Chief Financial Officer), who sold $25.8K worth of shares on Jan 5, 2026. Biohaven Ltd. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $1.08B.
Buys (12M)
4
$33.14M
Sells (12M)
5
$153.7K
Net Activity
Net Buyer
$32.99M
Active Insiders
9
last 12 mo
BHVN Price Chart
BHVN Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026↗ | Buten Matthew | Chief Financial Officer | Sell | 2,594 | $9.93 | $25.8K | 0 |
| Jan 5, 2026↗ | Car Bruce | Chief Scientific Officer | Sell | 2,381 | $9.93 | $23.6K | 0 |
| Jan 5, 2026↗ | Clark George C. | VP, Chief Accounting Officer | Sell | 1,117 | $9.93 | $11.1K | 0 |
| Jan 5, 2026↗ | Coric Vlad | Chief Executive Officer | Sell | 7,430 | $9.93 | $73.8K | 0 |
| Jan 5, 2026↗ | Gentile Kimberly | SVP, Clinical Operations | Sell | 1,956 | $9.93 | $19.4K | 0 |
| Nov 17, 2025↗ | Clark George C. | VP, Chief Accounting Officer | Buy | 17,000 | $8.52 | $144.8K | 0 |
| Nov 13, 2025↗ | Bailey Gregory | Director | Buy | 400,000 | $7.50 | $3.00M | 0 |
| Nov 13, 2025↗ | CHILDS JOHN W | Director | Buy | 3,333,333 | $7.50 | $25.00M | 0 |
| Nov 13, 2025↗ | Coric Vlad | Chief Executive Officer | Buy | 666,666 | $7.50 | $5.00M | 0 |
| Mar 4, 2025↗ | CHILDS JOHN W | Director | Buy | 32,700 | $30.47 | $996.2K | 0 |
| Jan 5, 2025↗ | Buten Matthew | Chief Financial Officer | Sell | 2,561 | $38.64 | $99.0K | 0 |
| Jan 5, 2025↗ | Car Bruce | Chief Scientific Officer | Sell | 2,331 | $38.64 | $90.1K | 0 |
| Jan 5, 2025↗ | Clark George C. | VP, Chief Accounting Officer | Sell | 1,117 | $38.64 | $43.2K | 0 |
| Jan 5, 2025↗ | Coric Vlad | Chief Executive Officer | Sell | 6,805 | $38.64 | $262.9K | 0 |
| Jan 5, 2025↗ | Gentile Kimberly | SVP, Clinical Operations | Sell | 1,956 | $38.64 | $75.6K | 0 |
| Dec 30, 2024↗ | CHILDS JOHN W | Director | Buy | 29,000 | $35.94 | $1.04M | 0 |
| Oct 2, 2024↗ | CHILDS JOHN W | Director | Buy | 21,052 | $47.50 | $1000.0K | 0 |
| Oct 2, 2024↗ | Coric Vlad | Chief Executive Officer | Buy | 21,052 | $47.50 | $1000.0K | 0 |
| Sep 24, 2024↗ | Bailey Gregory | Director | Buy | 5,000 | $44.19 | $221.0K | 0 |
| Jul 18, 2024↗ | CHILDS JOHN W | Director | Buy | 28,400 | $35.67 | $1.01M | 0 |
| Jun 17, 2024↗ | Car Bruce | Chief Scientific Officer | Buy | 30,000 | $33.58 | $1.01M | 0 |
| May 30, 2024↗ | CHILDS JOHN W | Director | Buy | 28,000 | $35.58 | $996.2K | 0 |
| May 13, 2024↗ | Bailey Gregory | Director | Buy | 15,000 | $34.19 | $512.9K | 0 |
| May 13, 2024↗ | CHILDS JOHN W | Director | Buy | 28,500 | $35.17 | $1.00M | 0 |
| Apr 24, 2024↗ | Bailey Gregory | Director | Buy | 25,503 | $39.18 | $999.2K | 0 |
| Apr 22, 2024↗ | Bailey Gregory | Director | Buy | 48,780 | $41.00 | $2.00M | 0 |
| Apr 22, 2024↗ | CHILDS JOHN W | Director | Buy | 195,121 | $41.00 | $8.00M | 0 |
| Apr 22, 2024↗ | Coric Vlad | Chief Executive Officer | Buy | 121,951 | $41.00 | $5.00M | 0 |
| Dec 29, 2023↗ | Antonijevic Irina | Director | Sell | 11,000 | $41.79 | $459.7K | 0 |
| Oct 5, 2023↗ | Buten Matthew | Chief Financial Officer | Buy | 22,727 | $22.00 | $500.0K | 0 |
| Oct 5, 2023↗ | CHILDS JOHN W | Director | Buy | 454,545 | $22.00 | $10.00M | 0 |
| Oct 5, 2023↗ | Coric Vlad | Chief Executive Officer | Buy | 454,545 | $22.00 | $10.00M | 0 |
| Oct 4, 2023↗ | Bailey Gregory | Director | Buy | 17,817 | $22.57 | $402.1K | 0 |
| Aug 30, 2023↗ | CHILDS JOHN W | Director | Buy | 50,000 | $18.44 | $922.2K | 0 |
| Aug 4, 2023↗ | CHILDS JOHN W | Director | Buy | 100,000 | $19.78 | $1.98M | 0 |
| Oct 31, 2022↗ | Coric Vlad | Chief Executive Officer | Buy | 25,800 | $15.97 | $412.0K | 0 |
| Oct 28, 2022↗ | Coric Vlad | Chief Executive Officer | Buy | 141,930 | $14.84 | $2.11M | 0 |
| Oct 25, 2022↗ | Bailey Gregory | Director | Buy | 200,000 | $10.50 | $2.10M | 0 |
| Oct 25, 2022↗ | Buten Matthew | Chief Financial Officer | Buy | 142,857 | $10.50 | $1.50M | 0 |
| Oct 25, 2022↗ | CHILDS JOHN W | Director | Buy | 3,900,000 | $10.50 | $40.95M | 0 |
| Oct 25, 2022↗ | Coric Vlad | Chief Executive Officer | Buy | 853,380 | $10.50 | $8.96M | 0 |
| Oct 25, 2022↗ | GREGORY JULIA P | Director | Buy | 9,523 | $10.50 | $100.0K | 0 |
| Oct 5, 2022↗ | CHILDS JOHN W | Director | Buy | 274,141 | $8.98 | $2.46M | 0 |
| Oct 5, 2022↗ | Coric Vlad | Chief Executive Officer | Buy | 485,775 | $10.31 | $5.01M | 0 |
| Oct 3, 2022↗ | Bailey Gregory | Director | Sell | 11,975 | $7.50 | $89.8K | 0 |
| Oct 3, 2022↗ | Buten Matthew | Chief Financial Officer | Sell | 11,042 | $7.50 | $82.8K | 0 |
| Oct 3, 2022↗ | CHILDS JOHN W | Director | Sell | 5,507 | $7.50 | $41.3K | 0 |
| Oct 3, 2022↗ | Coric Vlad | Chief Executive Officer | Sell | 115,940 | $7.50 | $869.5K | 0 |
| Oct 3, 2022↗ | Gentile Kimberly | SVP, Clinical Operations | Sell | 37,492 | $7.00 | $262.4K | 0 |
| Oct 3, 2022↗ | GREGORY JULIA P | Director | Sell | 11,975 | $7.50 | $89.8K | 0 |
| Oct 3, 2022↗ | Heffernan Michael Thomas | Director | Sell | 5,507 | $7.50 | $41.3K | 0 |
| Oct 3, 2022↗ | HUGIN ROBERT J | Director | Sell | 3,263 | $7.50 | $24.5K | 0 |
| Oct 3, 2022↗ | Mehta Kishan | Director | Sell | 11,716 | $7.00 | $82.0K | 0 |
BHVN Insider Buying Activity
The following table shows recent insider purchases of Biohaven Ltd. (BHVN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 17, 2025↗ | Clark George C. | VP, Chief Accounting Officer | Buy | 17,000 | $8.52 | $144.8K | 0 |
| Nov 13, 2025↗ | Bailey Gregory | Director | Buy | 400,000 | $7.50 | $3.00M | 0 |
| Nov 13, 2025↗ | CHILDS JOHN W | Director | Buy | 3,333,333 | $7.50 | $25.00M | 0 |
| Nov 13, 2025↗ | Coric Vlad | Chief Executive Officer | Buy | 666,666 | $7.50 | $5.00M | 0 |
| Mar 4, 2025↗ | CHILDS JOHN W | Director | Buy | 32,700 | $30.47 | $996.2K | 0 |
| Dec 30, 2024↗ | CHILDS JOHN W | Director | Buy | 29,000 | $35.94 | $1.04M | 0 |
| Oct 2, 2024↗ | CHILDS JOHN W | Director | Buy | 21,052 | $47.50 | $1000.0K | 0 |
| Oct 2, 2024↗ | Coric Vlad | Chief Executive Officer | Buy | 21,052 | $47.50 | $1000.0K | 0 |
| Sep 24, 2024↗ | Bailey Gregory | Director | Buy | 5,000 | $44.19 | $221.0K | 0 |
| Jul 18, 2024↗ | CHILDS JOHN W | Director | Buy | 28,400 | $35.67 | $1.01M | 0 |
| Jun 17, 2024↗ | Car Bruce | Chief Scientific Officer | Buy | 30,000 | $33.58 | $1.01M | 0 |
| May 30, 2024↗ | CHILDS JOHN W | Director | Buy | 28,000 | $35.58 | $996.2K | 0 |
| May 13, 2024↗ | Bailey Gregory | Director | Buy | 15,000 | $34.19 | $512.9K | 0 |
| May 13, 2024↗ | CHILDS JOHN W | Director | Buy | 28,500 | $35.17 | $1.00M | 0 |
| Apr 24, 2024↗ | Bailey Gregory | Director | Buy | 25,503 | $39.18 | $999.2K | 0 |
| Apr 22, 2024↗ | Bailey Gregory | Director | Buy | 48,780 | $41.00 | $2.00M | 0 |
| Apr 22, 2024↗ | CHILDS JOHN W | Director | Buy | 195,121 | $41.00 | $8.00M | 0 |
| Apr 22, 2024↗ | Coric Vlad | Chief Executive Officer | Buy | 121,951 | $41.00 | $5.00M | 0 |
| Oct 5, 2023↗ | Buten Matthew | Chief Financial Officer | Buy | 22,727 | $22.00 | $500.0K | 0 |
| Oct 5, 2023↗ | CHILDS JOHN W | Director | Buy | 454,545 | $22.00 | $10.00M | 0 |
| Oct 5, 2023↗ | Coric Vlad | Chief Executive Officer | Buy | 454,545 | $22.00 | $10.00M | 0 |
| Oct 4, 2023↗ | Bailey Gregory | Director | Buy | 17,817 | $22.57 | $402.1K | 0 |
| Aug 30, 2023↗ | CHILDS JOHN W | Director | Buy | 50,000 | $18.44 | $922.2K | 0 |
| Aug 4, 2023↗ | CHILDS JOHN W | Director | Buy | 100,000 | $19.78 | $1.98M | 0 |
| Oct 31, 2022↗ | Coric Vlad | Chief Executive Officer | Buy | 25,800 | $15.97 | $412.0K | 0 |
| Oct 28, 2022↗ | Coric Vlad | Chief Executive Officer | Buy | 141,930 | $14.84 | $2.11M | 0 |
| Oct 25, 2022↗ | Bailey Gregory | Director | Buy | 200,000 | $10.50 | $2.10M | 0 |
| Oct 25, 2022↗ | Buten Matthew | Chief Financial Officer | Buy | 142,857 | $10.50 | $1.50M | 0 |
| Oct 25, 2022↗ | CHILDS JOHN W | Director | Buy | 3,900,000 | $10.50 | $40.95M | 0 |
| Oct 25, 2022↗ | Coric Vlad | Chief Executive Officer | Buy | 853,380 | $10.50 | $8.96M | 0 |
| Oct 25, 2022↗ | GREGORY JULIA P | Director | Buy | 9,523 | $10.50 | $100.0K | 0 |
| Oct 5, 2022↗ | CHILDS JOHN W | Director | Buy | 274,141 | $8.98 | $2.46M | 0 |
| Oct 5, 2022↗ | Coric Vlad | Chief Executive Officer | Buy | 485,775 | $10.31 | $5.01M | 0 |
BHVN Insider Selling Activity
The following table shows recent insider sales of Biohaven Ltd. (BHVN) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Jan 5, 2026↗ | Buten Matthew | Chief Financial Officer | Sell | 2,594 | $9.93 | $25.8K | 0 |
| Jan 5, 2026↗ | Car Bruce | Chief Scientific Officer | Sell | 2,381 | $9.93 | $23.6K | 0 |
| Jan 5, 2026↗ | Clark George C. | VP, Chief Accounting Officer | Sell | 1,117 | $9.93 | $11.1K | 0 |
| Jan 5, 2026↗ | Coric Vlad | Chief Executive Officer | Sell | 7,430 | $9.93 | $73.8K | 0 |
| Jan 5, 2026↗ | Gentile Kimberly | SVP, Clinical Operations | Sell | 1,956 | $9.93 | $19.4K | 0 |
| Jan 5, 2025↗ | Buten Matthew | Chief Financial Officer | Sell | 2,561 | $38.64 | $99.0K | 0 |
| Jan 5, 2025↗ | Car Bruce | Chief Scientific Officer | Sell | 2,331 | $38.64 | $90.1K | 0 |
| Jan 5, 2025↗ | Clark George C. | VP, Chief Accounting Officer | Sell | 1,117 | $38.64 | $43.2K | 0 |
| Jan 5, 2025↗ | Coric Vlad | Chief Executive Officer | Sell | 6,805 | $38.64 | $262.9K | 0 |
| Jan 5, 2025↗ | Gentile Kimberly | SVP, Clinical Operations | Sell | 1,956 | $38.64 | $75.6K | 0 |
| Dec 29, 2023↗ | Antonijevic Irina | Director | Sell | 11,000 | $41.79 | $459.7K | 0 |
| Oct 3, 2022↗ | Bailey Gregory | Director | Sell | 11,975 | $7.50 | $89.8K | 0 |
| Oct 3, 2022↗ | Buten Matthew | Chief Financial Officer | Sell | 11,042 | $7.50 | $82.8K | 0 |
| Oct 3, 2022↗ | CHILDS JOHN W | Director | Sell | 5,507 | $7.50 | $41.3K | 0 |
| Oct 3, 2022↗ | Coric Vlad | Chief Executive Officer | Sell | 115,940 | $7.50 | $869.5K | 0 |
| Oct 3, 2022↗ | Gentile Kimberly | SVP, Clinical Operations | Sell | 37,492 | $7.00 | $262.4K | 0 |
| Oct 3, 2022↗ | GREGORY JULIA P | Director | Sell | 11,975 | $7.50 | $89.8K | 0 |
| Oct 3, 2022↗ | Heffernan Michael Thomas | Director | Sell | 5,507 | $7.50 | $41.3K | 0 |
| Oct 3, 2022↗ | HUGIN ROBERT J | Director | Sell | 3,263 | $7.50 | $24.5K | 0 |
| Oct 3, 2022↗ | Mehta Kishan | Director | Sell | 11,716 | $7.00 | $82.0K | 0 |
BHVN Insiders
Similar Stocks to BHVN
VRTX
Vertex Pharmaceuticals Incorporated
$470.20-1.66%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$743.51-0.41%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$313.45-1.19%
$42.07B
INSM
Insmed Incorporated
$139.06-0.33%
$30.07B
UTHR
United Therapeutics Corporation
$536.12+0.97%
$23.50B
MRNA
Moderna, Inc.
$52.56-1.89%
$20.76B
ROIV
Roivant Sciences Ltd.
$28.06-1.44%
$20.08B
RPRX
Royalty Pharma plc
$45.65-0.57%
$19.56B